Skip to main content

Table 3 Effects of different treatment options on hospital and Intensive care unit stay of patients, modeled with univariate and multivariate linear regression

From: Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?

Drugs Intensive Care Unit Stay Hospital Stay
Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
Coefficient (se*) P value Coefficient (se) P value Coefficient (se) P value Coefficient (se) P value
Hydroxychloroquine 2.456 (1.44) 0.09 1.636 (1.02) 0.12 1.55 (2.21) 0.485
Interferon 3.97 (2.23) 0.08 0.759 (3.05) 0.80 1.39 (3.41) 0.685
Lopinavir/Ritonavir 7.83 (1.229) < 0.001 5.309 (1.23) < 0.001 3.27 (2.31) 0.161 3.44 (3.06) 0.27
Remdesivir 0.91 0.03 0.721(0.21) 0.03 − 0.77 (2.14) 0.01 0.10 (2.00) < 0.001
High dose methylprednisolone or dexamethasone 0.103 (1.56) 0.94 1.572 (2.40) 0.514
Tocilizumab 0.71 0.02 0.66(0.10) < 0.001 0.90 (1.10) 0.04 0.22 0.04
  1. *Standard error